Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12618059 | Anc80 encoding sphingolipid-metabolizing proteins | 🖼🧊📄§ | 2026-05-05 | 2039-03-07 | 0 | 31 |
| 12617825 | Methods and compositions for reducing the immunogenicity of chimeric notch receptors | 🖼🧊📄§ | 2026-05-05 | 2042-04-08 | 0 | 31 |
| 12618024 | Microcell systems for controlled release of fragrances | 🖼🧊📄§ | 2026-05-05 | 2042-12-20 | 0 | 31 |
| 12618044 | Specification of functional cranial placode derivatives from human pluripotent stem cells | 🖼🧊📄§ | 2026-05-05 | 2042-12-21 | 0 | 31 |
| 12617858 | Anti-Müllerian hormone receptor 2 antibodies and methods of use | 🖼🧊📄§ | 2026-05-05 | 2041-01-29 | 0 | 31 |
| 12616646 | Use of rochelle salt | 🖼🧊📄§ | 2026-05-05 | 2041-12-15 | 0 | 31 |
| 12617861 | Anti-OX40 antibody and method of treatment | 🖼🧊📄§ | 2026-05-05 | 2041-04-16 | 0 | 31 |
| 12616662 | Lipid particles for nucleic acid delivery and clinical applications of same | 🖼🧊📄§ | 2026-05-05 | 2042-11-17 | 0 | 31 |
| 12617809 | Cardioprotective lipid and method of use | 🖼🧊📄§ | 2026-05-05 | 2042-09-22 | 0 | 31 |
| 12616656 | Adventitial painting modality of local drug delivery to abate intimal hyperplasia | 🖼🧊📄§ | 2026-05-05 | 2042-05-20 | 0 | 31 |
| 12616734 | Chimeric antigen receptor specifically binding to cd 300C antigen or receptor thereof | 🖼🧊📄§ | 2026-05-05 | 2042-05-27 | 0 | 31 |
| 12616723 | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity | 🖼🧊📄§ | 2026-05-05 | 2043-11-13 | 0 | 31 |
| 12618065 | MiRNA detargeting system for tissue specific interference | 🖼🧊📄§ | 2026-05-05 | 2038-10-02 | 0 | 31 |
| 12618066 | Promoter having high activity in activated T-cell | 🖼🧊📄§ | 2026-05-05 | 2040-11-13 | 0 | 31 |
| 12618076 | Methods of engineering platelets for targeting circulating tumor cells | 🖼🧊📄§ | 2026-05-05 | 2040-09-30 | 0 | 31 |
| 12618082 | Engineered muscle targeting compositions | 🖼🧊📄§ | 2026-05-05 | 2042-03-29 | 0 | 31 |
| 12617762 | Carboxy derivatives with antiinflamatory properties | 🖼🧊📄§ | 2026-05-05 | 2040-12-23 | 0 | 31 |
| 12617790 | Mitragynine analogs and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-06-24 | 0 | 31 |
| 12617805 | Codrug that disintegrates in intestine, preparation therefor, and use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-07-19 | 0 | 31 |
| 12617812 | Platinum(IV) complexes, methods of manufacture, compositions containing, and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2042-05-25 | 0 | 31 |
| 12617807 | Long lasting opioid reversal using hydrogen peroxide-induced release in blood | 🖼🧊📄§ | 2026-05-05 | 2042-04-01 | 0 | 31 |
| 12617822 | Arc-based capsids and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2042-10-13 | 0 | 31 |
| 12617820 | Engineered coronavirus spike (s) protein and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-05-28 | 0 | 31 |
| 12617828 | Genetically modified immune cell, preparation method therefor, and application | 🖼🧊📄§ | 2026-05-05 | 2040-05-06 | 0 | 31 |
| 12617826 | CLEC2 fusion protein and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-09-29 | 0 | 31 |
| 12617831 | Peptide targeting GIP and GLP-2 receptors for treating bone disorders | 🖼🧊📄§ | 2026-05-05 | 2040-02-21 | 0 | 31 |
| 12617833 | Tethered interleukin-15 and interleukin-21 | 🖼🧊📄§ | 2026-05-05 | 2039-02-07 | 0 | 31 |
| 12617832 | Genetic engineering of B cell receptors and uses thereof in antigen-induced antibody secretion | 🖼🧊📄§ | 2026-05-05 | 2041-03-12 | 0 | 31 |
| 12617836 | Tumor environment specific expression of effector genes | 🖼🧊📄§ | 2026-05-05 | 2042-03-21 | 0 | 31 |
| 12617837 | Composition for use in treatment of allergic diseases | 🖼🧊📄§ | 2026-05-05 | 2040-02-28 | 0 | 31 |
| 12617839 | Factor VIII chimeric proteins and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-11-05 | 0 | 31 |
| 12617841 | Nucleic acid antibody constructs for use against respiratory syncytial virus | 🖼🧊📄§ | 2026-05-05 | 2039-01-31 | 0 | 31 |
| 12617850 | Treatment of PD-L1-positive melanoma using an anti-PD-1 antibody | 🖼🧊📄§ | 2026-05-05 | 2042-03-22 | 0 | 31 |
| 12617849 | Antigen specific CD19-targeted CAR-T cells | 🖼🧊📄§ | 2026-05-05 | 2040-04-29 | 0 | 31 |
| 12617856 | Protease-cleavable substrates and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2045-03-17 | 0 | 31 |
| 12617867 | Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereof | 🖼🧊📄§ | 2026-05-05 | 2039-09-25 | 0 | 31 |
| 12617870 | Methods of reversing ticagrelor activity | 🖼🧊📄§ | 2026-05-05 | 2039-09-20 | 0 | 31 |
| 12617864 | Methods of activating and proliferating exhausted CD8 T cells, CD8 T cells with enhanced activity prepared by the same, and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2042-04-12 | 0 | 31 |
| 12617866 | Humanized antibodies to mucin-16 and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2040-05-07 | 0 | 31 |
| 12616668 | Nutritional supplement containing L-α-glycerophosphorylcholine | 🖼🧊📄§ | 2026-05-05 | 2044-01-22 | 0 | 31 |
| 12616664 | Myo-inositol and the prevention of preterm birth | 🖼🧊📄§ | 2026-05-05 | 2040-08-21 | 0 | 31 |
| 12616666 | Coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa | 🖼🧊📄§ | 2026-05-05 | 2042-07-13 | 0 | 31 |
| 12616669 | Methods and chemical compositions for treating skin conditions by providing long lasting skin pH control for improving skin barrier function | 🖼🧊📄§ | 2026-05-05 | 2045-08-27 | 0 | 31 |
| 12616658 | Method for preparation of liposomes | 🖼🧊📄§ | 2026-05-05 | 2041-07-01 | 0 | 31 |
| 12616659 | Therapeutic agent nanoparticles and methods of preparation | 🖼🧊📄§ | 2026-05-05 | 2043-05-24 | 0 | 31 |
| 12616657 | Cell-targeted nanoparticles to inhibit RNA cargo | 🖼🧊📄§ | 2026-05-05 | 2041-02-26 | 0 | 31 |
| 12616644 | Polyurethane gels | 🖼🧊📄§ | 2026-05-05 | 2040-07-10 | 0 | 31 |
| 12616651 | Topical lipolysis composition and methods | 🖼🧊📄§ | 2026-05-05 | 2041-10-07 | 0 | 31 |
| 12616650 | Radiation sensitizer of anti-cancer chemotherapy sensitizer | 🖼🧊📄§ | 2026-05-05 | 2040-07-23 | 0 | 31 |
| 12616747 | Stabilized beta-coronavirus antigens | 🖼🧊📄§ | 2026-05-05 | 2042-12-02 | 0 | 31 |